The current state of acute treatment for migraine in adults in the United States-Reference-Cited by-同舟云学术

The current state of acute treatment for migraine in adults in the United States

Published:2020-05-27 Issue:7 Volume:132 Page:581-589
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Cooper Wade¹,Doty Erin Gautier²^ORCID,Hochstetler Helen²,Hake Ann²,Martin Vincent³

Affiliation:

1. University of Michigan, Department of Neurology, Headache and Neuropathic Pain Program, Ann Arbor, MI, USA

2. Eli Lilly and Company, Indianapolis, IN, USA

3. University of Cincinnati, College of Medicine, Department of Internal Medicine, Cincinnati, OH, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2020.1767402

Reference77 articles.

1. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

2. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants

3. Facts about migraine [Internet]. Mount Royal (NJ): American Migraine Foundation; 2019 [cited 2019 Feb 12]. Available from: https://americanmigrainefoundation.org/wp-content/uploads/2019/03/Facts-About-Migraine-AMF.pdf

4. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Use of Rimegepant 75 mg for the Acute Treatment of Migraine is Associated with a Reduction in the Utilization of Select Analgesics and Antiemetics;Journal of Pain Research;2024-05

2. Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial;The Journal of Headache and Pain;2024-04-16

3. Evidence-based symptomatic treatment of migraine;Handbook of Clinical Neurology;2024

4. Modern strategies for the treatment of migraine attacks and the possibility of a differentiated approach;Meditsinskiy sovet = Medical Council;2023-11-23

5. Effectiveness of integrated education and relaxation program on migraine-related disability: a randomized controlled trial;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2023-10-31